Bridger Management has fully exited its position in Masimo (MASI), selling 47,841 shares and reducing its holdings by $7.06 million, according to an SEC filing dated February 17, 2026. This decision comes after a challenging quarter for Masimo, which saw its shares dip approximately 12%. As of the filing, Masimo shares were trading at $178.24, reflecting a modest 5% increase over the past year, significantly lagging behind the S&P 500’s 15% gain.
The sale highlights the impact of market timing, particularly in the medtech sector, where volatility can be pronounced. Just weeks after Bridger’s exit, Masimo announced a $9.9 billion acquisition deal at $180 per share, resulting in a 34% surge in its stock price. This underscores the potential for significant upside in event-driven scenarios, even amid a challenging environment.
For investors, this situation emphasizes the importance of maintaining a long-term perspective. While selling during downturns may appear prudent, it can also mean missing out on transformative opportunities that arise unexpectedly.
Source: fool.com